US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
CA2328496C
(en)
|
1998-05-15 |
2016-01-05 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
JP2003508011A
(en)
*
|
1999-02-25 |
2003-03-04 |
トマス・ジエフアーソン・ユニバーシテイ |
Compositions, kits and methods relating to a novel tumor suppressor gene that is the human FEZ1 gene
|
WO2000050458A1
(en)
*
|
1999-02-26 |
2000-08-31 |
Smithkline Beecham Corporation |
Cloning of a p2y-like 7tm receptor (axor17)
|
AU3885400A
(en)
*
|
1999-03-23 |
2000-10-09 |
Human Genome Sciences, Inc. |
48 human secreted proteins
|
EP1174509A4
(en)
|
1999-03-29 |
2003-10-22 |
Kansai Tech Licensing Org Co |
Novel cytidine deaminase
|
EP1623993A3
(en)
*
|
1999-09-01 |
2006-06-07 |
Genetech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7083944B1
(en)
*
|
1999-10-27 |
2006-08-01 |
Millennium Pharmaceuticals, Inc. |
Molecules of the card-related protein family and uses thereof
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
EP1878795A3
(en)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
CA2494705A1
(en)
*
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
CN1300781A
(en)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
ES2360155T3
(en)
|
2000-01-26 |
2011-06-01 |
Agensys, Inc. |
84P2A9: A SPECIFIC PROTEIN OF PROSTATE AND TESTICLES HIGHLY EXPRESSED IN PROSTATE CANCER.
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
AU2001250980A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Carmela Beger |
Brca-1 regulators and methods of use
|
EP1272640A2
(en)
|
2000-03-24 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
AU2001257195B2
(en)
*
|
2000-04-25 |
2006-10-05 |
Lexicon Pharmaceuticals, Inc. |
Novel human kinase proteins and polynucleotides encoding the same
|
EP1280917A2
(en)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
WO2001085921A2
(en)
*
|
2000-05-12 |
2001-11-15 |
Merck Patent Gmbh |
Human serine-threonine kinase-4
|
EP1307545A2
(en)
*
|
2000-05-26 |
2003-05-07 |
Bayer Aktiengesellschaft |
REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
|
EP1158001B1
(en)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
|
DE10027170A1
(en)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Human PEM as a target for fertility control
|
WO2001093805A2
(en)
*
|
2000-06-02 |
2001-12-13 |
The Brigham & Women's Hospital, Inc. |
FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1292677A2
(en)
*
|
2000-06-05 |
2003-03-19 |
Bayer Aktiengesellschaft |
Human hm74-like g protein coupled receptor
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
CA2411278A1
(en)
*
|
2000-06-09 |
2001-12-20 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
AU2001268435A1
(en)
*
|
2000-06-15 |
2001-12-24 |
Millennium Pharmaceuticals, Inc. |
23680, a novel human aminotransferase and uses therefor
|
AU2001269888A1
(en)
*
|
2000-06-16 |
2001-12-24 |
Incyte Genomics, Inc. |
Protein phosphatases
|
EP2075253A1
(en)
*
|
2000-06-23 |
2009-07-01 |
Genentech, Inc. |
Compositions and methds for the diagnosis and treatment of disorders involving angiogensis
|
EP1325114A2
(en)
*
|
2000-06-26 |
2003-07-09 |
Millennium Pharmaceuticals, Inc. |
A human beta-ketoacyl synthase (46619) and uses thereof
|
JP2004501623A
(en)
*
|
2000-06-27 |
2004-01-22 |
キュラジェン コーポレイション |
Polynucleotides and polypeptides encoded thereby
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
AU2001271621A1
(en)
|
2000-06-28 |
2002-01-08 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
AU2001273148A1
(en)
|
2000-06-30 |
2002-01-14 |
Millennium Pharmaceuticals, Inc. |
57658, a human uridine kinase and uses thereof
|
WO2002004510A2
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Gtp-binding proteins
|
JP2004513618A
(en)
*
|
2000-07-07 |
2004-05-13 |
インサイト・ゲノミックス・インコーポレイテッド |
Transporters and ion channels
|
EP1305428A2
(en)
*
|
2000-07-14 |
2003-05-02 |
Millennium Pharmaceuticals, Inc. |
62088, a human nucleoside phosphatase family member and uses thereof
|
AU2001281967A1
(en)
*
|
2000-07-18 |
2002-01-30 |
Bayer Aktiengesellschaft |
Regulation of human desc1-like serine protease
|
US6740751B2
(en)
|
2000-07-18 |
2004-05-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
|
JP2004514420A
(en)
*
|
2000-07-20 |
2004-05-20 |
ジェネンテック・インコーポレーテッド |
Secreted and transmembrane polypeptides and nucleic acids encoding them
|
US20060252034A1
(en)
*
|
2000-07-25 |
2006-11-09 |
Klaus Duecker |
Novel protein containing ring finger domaine r1p4
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
AU2001277200A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-cad protein and related reagents and methods of use thereof
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
EP1657254A3
(en)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
|
WO2002010217A2
(en)
|
2000-08-02 |
2002-02-07 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
WO2003024276A1
(en)
*
|
2000-08-02 |
2003-03-27 |
Millennium Pharmaceuticals,Inc. |
A human gtp-releasing factor family member (15368) and uses therefor
|
US6924364B2
(en)
|
2000-08-04 |
2005-08-02 |
Zymogenetics, Inc. |
Human secreted protein, Zzp1
|
US6943245B2
(en)
|
2000-08-10 |
2005-09-13 |
Board Of Regents, The University Of Texas System |
Tumor suppressor CAR-1
|
US7091022B2
(en)
*
|
2000-08-11 |
2006-08-15 |
Merck Patent Gmbh |
Mitogen activated kinase
|
EP1326985A1
(en)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification of a human n-terminal acetyltransferase gene
|
CA2417186A1
(en)
*
|
2000-08-21 |
2002-02-28 |
Incyte Genomics, Inc. |
Microtubule-associated proteins and tubulins
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
WO2002016579A2
(en)
*
|
2000-08-24 |
2002-02-28 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
WO2002018578A2
(en)
*
|
2000-08-28 |
2002-03-07 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
EP1334189A2
(en)
*
|
2000-08-28 |
2003-08-13 |
AstraZeneca AB |
Molecules involved in the regulation of insulin resistance syndrome (irs)
|
CA2420902A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Craig A. Rosen |
18 human secreted proteins
|
AU2001286714A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
54370, a novel human sulfate transporter and uses therefor
|
US20020146800A1
(en)
*
|
2000-08-30 |
2002-10-10 |
Curtis Rory A.J. |
48921, a novel human GTP releasing factor and uses therefor
|
WO2002018567A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
AU2001285908A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
WO2002018582A2
(en)
*
|
2000-08-31 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
CA2421588C
(en)
|
2000-09-05 |
2010-01-26 |
Amgen Inc. |
Tnf receptor-like molecules and uses thereof
|
EP1364015A2
(en)
*
|
2000-09-05 |
2003-11-26 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
US20020142464A1
(en)
*
|
2000-09-08 |
2002-10-03 |
Millennium Pharmaceuticals, Inc. |
38646, a novel guanine nucleotide exchange factor and uses therefor
|
US6372468B1
(en)
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
WO2002029058A2
(en)
*
|
2000-10-05 |
2002-04-11 |
Curagen Corporation |
Human proteins, polynucleotides encoding them and methods of using the same
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
EP1402010A2
(en)
*
|
2000-10-11 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
8843, a human dual specificity phosphatase family member and uses therefor
|
US20020064831A1
(en)
*
|
2000-10-12 |
2002-05-30 |
The Texas A&M University System |
Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use
|
AU2002215345A1
(en)
*
|
2000-10-13 |
2002-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
WO2002062945A2
(en)
|
2000-10-25 |
2002-08-15 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
AU2002220668A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
WO2002038743A2
(en)
*
|
2000-11-09 |
2002-05-16 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
EP1349934A2
(en)
|
2000-11-20 |
2003-10-08 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
WO2002081667A2
(en)
*
|
2000-12-05 |
2002-10-17 |
Incyte Genomics, Inc. |
Ligases
|
JP2004524825A
(en)
|
2000-12-07 |
2004-08-19 |
ザイモジェネティクス,インコーポレイティド |
Adipocyte complement-related protein ZACRP3X2
|
CA2430379A1
(en)
|
2000-12-07 |
2002-06-13 |
Chiron Corporation |
Endogenous retroviruses up-regulated in prostate cancer
|
CA2439800A1
(en)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
IL155687A0
(en)
|
2000-12-22 |
2003-11-23 |
Bristol Myers Squibb Co |
Polynucleotides encoding hlrrsi1 polypeptides
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6423521B1
(en)
*
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
WO2002053591A1
(en)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Mammalian nuclear receptor cofactor cf12 and methods of use
|
WO2002053754A2
(en)
*
|
2001-01-08 |
2002-07-11 |
Lexicon Genetics Incorporated |
Human protease and polynucleotides encoding the same
|
AU2002243750A1
(en)
*
|
2001-01-30 |
2002-08-12 |
Regeneron Pharmaceuticals, Inc. |
Novel nucleic acid and polypeptide molecules
|
WO2002098917A2
(en)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Human proteins and nucleic acids encoding same
|
EP1637601A3
(en)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
AU2002250143A1
(en)
*
|
2001-03-16 |
2002-10-03 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
WO2002083860A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
|
IL158293A0
(en)
|
2001-04-10 |
2004-05-12 |
Agensys Inc |
Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
|
AU2002249453A1
(en)
*
|
2001-04-24 |
2002-11-05 |
Isis Innovation Ltd |
Enzyme and snp marker for disease
|
EP1391462A4
(en)
*
|
2001-04-24 |
2004-09-15 |
Otsuka Pharma Co Ltd |
Crohn's disease antibody-binding peptide and method of examining crohn's disease
|
KR100882762B1
(en)
|
2001-05-07 |
2009-02-09 |
시오노기세이야쿠가부시키가이샤 |
Polypeptide serving as angiogenic marker and dna thereof
|
AU2002314048A1
(en)
*
|
2001-05-09 |
2002-11-18 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2003000901A2
(en)
*
|
2001-06-26 |
2003-01-03 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
US20030120040A1
(en)
|
2001-06-29 |
2003-06-26 |
Genentech, Inc. |
Secreted and Transmembrane polypeptides and nucleic acids encoding the same
|
GB2399087A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ7
|
JP2005504546A
(en)
*
|
2001-08-17 |
2005-02-17 |
インサイト・ゲノミックス・インコーポレイテッド |
Intracellular signaling molecules
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
WO2003023063A1
(en)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Method of judging onset risk of diabetes
|
WO2003040369A2
(en)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
|
WO2003025175A2
(en)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
|
WO2003029411A2
(en)
|
2001-09-28 |
2003-04-10 |
Brigham Young University |
Novel cyclooxygenase variants and methods of use
|
JPWO2003038087A1
(en)
|
2001-10-04 |
2005-02-24 |
関西ティー・エル・オー株式会社 |
Promoter of DR5 gene and promoter of Siah-1 gene
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003031607A1
(en)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation of human short-chain dehydrogenase/reductase
|
DE60220621T2
(en)
|
2001-11-09 |
2008-03-06 |
Proteologics, Inc. |
Posh nucleic acid, polypeptides and related methods
|
US7491690B2
(en)
|
2001-11-14 |
2009-02-17 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
WO2003044197A1
(en)
*
|
2001-11-21 |
2003-05-30 |
Japan Science And Technology Agency |
Huntington’s disease gene transcriptional factors
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
AU2002339697A1
(en)
*
|
2001-12-19 |
2003-06-30 |
Genset S.A. |
Gmg-5 polynucleotides and polypeptides and uses thereof
|
JP2003245084A
(en)
*
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
|
DE10163467A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
WO2003057870A1
(en)
*
|
2002-01-07 |
2003-07-17 |
Bayer Healthcare Ag |
Human phosphatidic acid phosphatase type 2-like protein
|
AU2003205611A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Medigene Ag |
Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
|
AU2003235631A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Bayer Aktiengesellschaft |
Human subtilisin/kexin-like convertase
|
JPWO2003062429A1
(en)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
New serine protease
|
US7371719B2
(en)
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
EP1338609A1
(en)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
A further KDR receptor and the use thereof
|
AU2003225666A1
(en)
*
|
2002-03-05 |
2003-09-22 |
Applera Corporation |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
WO2003074557A1
(en)
*
|
2002-03-06 |
2003-09-12 |
Oxford Glycosciences (Uk) Ltd |
Novel b-cell malignancy-associated protein
|
EP2799555B1
(en)
|
2002-03-13 |
2017-02-22 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
JP3949111B2
(en)
*
|
2002-03-19 |
2007-07-25 |
田辺製薬株式会社 |
Novel G protein-coupled receptor and gene thereof
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
CA2413475C
(en)
|
2002-04-25 |
2010-07-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
|
JP2004041003A
(en)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
New protein, its dna and use thereof
|
AU2003238178A1
(en)
|
2002-05-29 |
2003-12-12 |
Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
EP2275544A3
(en)
*
|
2002-06-06 |
2011-03-30 |
Oncotherapy Science, Inc. |
Genes and polypeptides relating to human colon cancers
|
CA2489292A1
(en)
|
2002-06-13 |
2003-12-24 |
Chiron Corporation |
Vectors for expression of hml-2 polypeptides
|
AU2003281626A1
(en)
*
|
2002-07-22 |
2004-02-09 |
Masayoshi Harigai |
Novel gene associated with rheumatoid arthritis
|
CA2495177C
(en)
|
2002-08-14 |
2014-01-21 |
National Institute Of Advanced Industrial Science And Technology |
Novel n-acetylgalactosamine transferases and nucleic acids encoding the same
|
US20040081653A1
(en)
*
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
US20060292564A1
(en)
*
|
2002-08-27 |
2006-12-28 |
Epigenomics Ag |
Method and nucleic acids for the analysis of breast cell proliferative disorders
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
JP4679149B2
(en)
|
2002-09-30 |
2011-04-27 |
オンコセラピー・サイエンス株式会社 |
Genes and polypeptides related to human pancreatic cancer
|
WO2004035823A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
US8008003B2
(en)
|
2002-11-15 |
2011-08-30 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004070025A2
(en)
*
|
2003-02-05 |
2004-08-19 |
Juan Saus |
Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
EP1445614A1
(en)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A method for the in vitro assessment of the progression status of an HIV virus in an invidual
|
US7074891B2
(en)
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
DK1597391T3
(en)
|
2003-02-20 |
2009-01-12 |
Genomic Health Inc |
Use of intron RNA to measure gene expression
|
JPWO2004078784A1
(en)
*
|
2003-03-04 |
2006-06-08 |
アステラス製薬株式会社 |
Novel genes related to fibrotic conditions
|
GEP20094629B
(en)
*
|
2003-03-19 |
2009-03-10 |
Biogen Idec Inc |
Nogo receptor binding protein
|
ITRM20030149A1
(en)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD
|
ES2488845T5
(en)
|
2003-06-24 |
2017-07-11 |
Genomic Health, Inc. |
Prediction of the probability of cancer recurrence
|
EP1644858B1
(en)
|
2003-07-10 |
2017-12-06 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
ATE528397T1
(en)
|
2003-08-08 |
2011-10-15 |
Perseus Proteomics Inc |
GENE OVEREXPRESSED IN CANCER
|
WO2005018554A2
(en)
*
|
2003-08-12 |
2005-03-03 |
Washington University In St. Louis |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
WO2005026314A2
(en)
*
|
2003-09-10 |
2005-03-24 |
Japan Science And Technology Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
DE602004028262D1
(en)
*
|
2003-10-02 |
2010-09-02 |
Glaxosmithkline Biolog Sa |
B. PERTUSSIS ANTIGENE AND ITS USE IN VACCINATION
|
WO2005033144A2
(en)
|
2003-10-03 |
2005-04-14 |
Brigham And Women's Hospital |
Tim-3 polypeptides
|
WO2005040791A2
(en)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
|
WO2005051994A2
(en)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Ztnf11, a tumor necrosis factor
|
KR20070004560A
(en)
|
2003-12-05 |
2007-01-09 |
노오쓰웨스턴 유니버시티 |
Self-assembling peptide amphiphiles and related methods for growth factor delivery
|
US20050196782A1
(en)
|
2003-12-23 |
2005-09-08 |
Kiefer Michael C. |
Universal amplification of fragmented RNA
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
LT3296407T
(en)
*
|
2004-03-02 |
2019-09-10 |
The Johns Hopkins University |
Mutations of the pik3ca gene in human cancers
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
KR101204286B1
(en)
*
|
2004-03-30 |
2012-11-26 |
엔에스진 에이/에스 |
Therapeutic use of a growth factor, NsG33
|
JP5813908B2
(en)
|
2004-04-09 |
2015-11-17 |
ジェノミック ヘルス, インコーポレイテッド |
Gene expression markers to predict response to chemotherapeutic agents
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
WO2005118832A2
(en)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
|
WO2006002437A2
(en)
|
2004-06-24 |
2006-01-05 |
Biogen Idec Ma Inc. |
Treatment of conditions involving demyelination
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
EP1780215B1
(en)
*
|
2004-08-05 |
2009-06-17 |
Toagosei Co., Ltd. |
Crohn's disease antibody epitope peptide and reagent for testing crohn's disease
|
US7930104B2
(en)
|
2004-11-05 |
2011-04-19 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
DK1815014T3
(en)
|
2004-11-05 |
2012-06-18 |
Genomic Health Inc |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
EP2314618A3
(en)
|
2004-11-12 |
2011-10-19 |
Xencor Inc. |
Fc variants with altered binding to FcRn
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
US7851445B2
(en)
|
2005-03-04 |
2010-12-14 |
Northwestern University |
Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use
|
EP1880005B1
(en)
*
|
2005-05-13 |
2012-11-07 |
Centre National de la Recherche Scientifique |
Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
|
EP2238986A3
(en)
|
2005-07-08 |
2010-11-03 |
Biogen Idec MA Inc. |
Sp35 antibodies and uses thereof
|
EP1907589A4
(en)
*
|
2005-07-26 |
2010-11-24 |
Siemens Healthcare Diagnostics |
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
|
WO2007037601A1
(en)
*
|
2005-09-28 |
2007-04-05 |
Knu-Industry Cooperation Foundation |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
EP1969003B8
(en)
|
2005-12-14 |
2010-11-10 |
Hermo Pharma Ltd. |
Uses of a NEUROTROPHIC FACTOR PROTEIN
|
AU2007271232A1
(en)
*
|
2006-07-03 |
2008-01-10 |
Exonhit Therapeutics Sa |
Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
|
US20080108070A1
(en)
*
|
2006-09-08 |
2008-05-08 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
GB0805159D0
(en)
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
ES2555282T3
(en)
*
|
2007-07-27 |
2015-12-30 |
Immatics Biotechnologies Gmbh |
New immunogenic epitopes for immunotherapy
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
WO2009034661A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Method for diagnosis and induction of resistance to virus
|
DK2216340T3
(en)
|
2007-10-17 |
2013-03-11 |
Univ Cordoba |
Isoforms of Alternative Treatment Human Type 5 Somatostatin Receptors and Oligonucleotide Pairs for Detection thereof by PCR
|
ES2742268T3
(en)
|
2007-12-26 |
2020-02-13 |
Xencor Inc |
Fc variants with altered FcRn binding
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
US9683031B2
(en)
|
2008-03-21 |
2017-06-20 |
Universiteit Hasselt |
Biomarkers for rheumatoid arthritis
|
US8058406B2
(en)
|
2008-07-09 |
2011-11-15 |
Biogen Idec Ma Inc. |
Composition comprising antibodies to LINGO or fragments thereof
|
AU2009273600B2
(en)
|
2008-07-24 |
2013-04-18 |
Hoba Therapeutics Aps |
Therapeutic use of a growth factor, METRNL
|
ES2536465T3
(en)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composition of tumor-associated and cancer-related peptides for the treatment of glioblastoma (GBM) and other cancers
|
EP2358908B1
(en)
|
2008-11-14 |
2014-01-08 |
Gen-Probe Incorporated |
Compositions and methods for detection of campylobacter nucleic acid
|
WO2010062960A2
(en)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
|
US20110286924A1
(en)
*
|
2008-12-09 |
2011-11-24 |
Alethia Biotherapeutics Inc |
Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
|
WO2010120830A1
(en)
|
2009-04-13 |
2010-10-21 |
Northwestern University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
AU2011210840B2
(en)
*
|
2010-01-27 |
2014-12-11 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
KR102504750B1
(en)
|
2010-09-29 |
2023-03-02 |
어젠시스 인코포레이티드 |
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
CN108079279B
(en)
|
2010-10-01 |
2022-04-12 |
霍巴治疗公司 |
Use of nickel-line protein for treating allodynia, hyperalgesia, spontaneous pain and phantom pain
|
ES2677699T3
(en)
|
2010-12-14 |
2018-08-06 |
Hananja Ehf |
Biological activity of placental protein 13
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
WO2013068445A1
(en)
*
|
2011-11-09 |
2013-05-16 |
Sanofi |
Diacylglycerol lipase and uses thereof
|
DK3489254T3
(en)
|
2012-04-30 |
2022-11-07 |
Biocon Ltd |
TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS OF MANUFACTURE THEREOF
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
JP2015518829A
(en)
|
2012-05-14 |
2015-07-06 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
LINGO-2 antagonist for treatment of conditions involving motor neurons
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
MX369276B
(en)
|
2012-11-13 |
2019-11-04 |
Biontech Ag |
Agents for treatment of claudin expressing cancer diseases.
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
US9023353B2
(en)
*
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
JP6671276B2
(en)
|
2013-03-27 |
2020-03-25 |
セダーズ−シナイ メディカル センター |
Alleviation and recovery of fibrosis and inflammation by suppression of TL1A function and related signaling pathways
|
LT3019619T
(en)
|
2013-07-11 |
2021-12-10 |
Modernatx, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
EP3022295A4
(en)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
RU2020106752A
(en)
|
2013-09-25 |
2020-03-11 |
Сайтомкс Терапьютикс, Инк. |
SUBSTRATES OF MATRIX METALLOPROTEINASES AND OTHER DISSOLIDABLE FRAGMENTS AND METHODS FOR USING THEM
|
CA2925658C
(en)
|
2013-10-01 |
2022-12-06 |
Mie University |
Long chain antigen containing interepitope sequence that promotes antigen presentation to t cells
|
EP4176896A1
(en)
|
2014-01-31 |
2023-05-10 |
Cytomx Therapeutics Inc. |
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
|
EP3242893A1
(en)
|
2015-01-08 |
2017-11-15 |
Biogen MA Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
MA41374A
(en)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF
|
EP3307070A4
(en)
*
|
2015-06-12 |
2019-01-02 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
US10351869B2
(en)
*
|
2015-09-04 |
2019-07-16 |
Synthetic Genomics, Inc. |
Microorganisms engineered for increased productivity
|
KR102464372B1
(en)
|
2016-03-17 |
2022-11-04 |
세다르스-신나이 메디칼 센터 |
Methods of diagnosing inflammatory bowel disease through rnaset2
|
WO2017172941A2
(en)
*
|
2016-03-29 |
2017-10-05 |
Berz David |
Modulation of structural maintenance of chromosome-1 expression
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
EP3508499A1
(en)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof
|
CA3146023A1
(en)
|
2019-07-05 |
2021-01-14 |
Iomx Therapeutics Ag |
Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
|
WO2021083958A1
(en)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Novel peptides inducing satiety
|
EP4149952A1
(en)
*
|
2020-05-12 |
2023-03-22 |
Institut Curie |
Neoantigenic epitopes associated with sf3b1 mutations
|
WO2022008027A1
(en)
|
2020-07-06 |
2022-01-13 |
Iomx Therapeutics Ag |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
AU2022209669A1
(en)
*
|
2021-01-21 |
2023-08-10 |
Erasmus University Medical Center Rotterdam |
T cells for use in therapy
|
AU2022222756A1
(en)
*
|
2021-02-18 |
2023-09-14 |
Beren Therapeutics P.B.C. |
Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
|
WO2023225602A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|